[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.237.138.69. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
June 1961

Triamcinolone Suspension in Alopecia Areata

Author Affiliations

CHICAGO

From the Section of Dermatology, Department of Medicine, University of Chicago.

Arch Dermatol. 1961;83(6):1004-1006. doi:10.1001/archderm.1961.01580120116030
Abstract

Introduction  The treatment of alopecia areata with systemically administered cortisone, first found to be effective by Dillaha and Rothman,1 poses the long-term practical problem of undesirable side-effects. Intralesional injection, on the other hand, permits localization of effective steroid dosages in selected sites without systemic effects. In spite of the fact that there are adrenal steroid compounds which satisfy both requirements of effectiveness in stimulating hair regrowth and of persistence in tissue, none have consistently maintained regrown hair for more than a few weeks to 9 months after cessation of treatment.2-5This is a report of the observations recorded in 4 patients with alopecia areata, selected for intralesional injections of triamcinolone suspension* to evaluate its usefulness in treatment of suitable cases with restricted hair loss.

Method  Single lesions or parts of lesions were injected subcutaneously each time with a total of 0.2 ml. (2 mg.) of 0.1% triamcinolone suspension

×